Blog
How Octozi Is Using AI to Accelerate Clinical Trials and Bring Drugs to Market Faster
By Michael Silver, Recruitment Consultant at Alldus Before reaching patients, every new drug must pass through the complex, time-consuming process of clinical development, where only 8% of candidates make it from Phase 1 to FDA approval. I had the privilege to speak with the founding team at Octozi to discuss why they believe they are solving this…
Read Article